-
Recent Posts
Recent Comments
- Geoff Vincent on 3 Reasons to Consider a Digital/Interactive Annual Report
- From the Tooth Fairy to Stem Cell Collection; Could Your Child’s Baby Teeth Save Lives? « It's PR not ER Blog on From the Tooth Fairy to Stem Cell Collection; Could Your Child’s Baby Teeth Save Lives?
- Dierdre Christi on Regenerative Medicine and Applications of Stem Cell Research
Archives
Categories
Meta
Category Archives: In the News
CEO David Wolf Featured in BioTuesday.com Interview
CLICK HERE TO READ THE FULL INTERVIEW Hamilton Thorne to accelerate acquisition program Hamilton Thorne (TSX-V:HTL), a leading provider of precision laser devices and advanced imaging systems, plans to accelerate its acquisition program, mainly in the human clinical in-vitro fertilization … Continue reading
Posted in Corporate Communications, In the News
Leave a comment
Supreme Court Settles Question in Stem Cell Funding
For the past three years, a cloud has hung over the question of US government funding for stem cell research. Earlier this week, the Supreme Court settled the issue when it denied certiorari in the case of Shirley v. Sebelius, … Continue reading
Posted in Corporate Communications, In the News
Leave a comment
Hamilton Thorne Ranked As Top 20 Medical Device Company By The Boston Business Journal
The October 12th, 2012 issue of the Boston Business Journal ranked Hamilton Thorne in their top 20 list of “Area’s Largest Medical Device Companies.” Hamilton Thorne is honored to have made the 2012 list and proud of the accomplishments that our employees have achieved to make … Continue reading
Posted in Corporate Communications, In the News
Leave a comment
How to Manage A Successful Webinar: 3 Key Elements
If your Company is evaluating the sales potential of a Webinar to promote your products or services, you must consider the following three foundational elements in order to be successful. Compelling Content: Yes, your products are bleeding-edge and have a … Continue reading
BIO Conference Comes to Boston But Still Has International Focus
I had recently attended the BIO International Conference, and although it was held in Hamilton Thorne’s backyard of Boston, it was great to see that the event is still very globally focused. In this interview of Jeremy Abbate of Scientific American, he … Continue reading
New Webinar on June 26 “Advantages of Using Lasers in Embryo Biopsy Procedures”
Hamilton Thorne is holding a FREE webinar entitled, “Advantages of Using Lasers in Embryo Biopsy Procedures.” Please register here if you would like to attend: https://www4.gotomeeting.com/register/428180015 Date and Time: June 26, 2012, … Continue reading
CEO Message on Q4 and Year-End Earnings for 2011; Record Revenues in Q4 and Eight Consecutive Quarters of Revenue Growth
“I am pleased to report that Hamilton Thorne performed well in 2011, achieving 19% growth and record sales of over $2 million in Q4, which marks our eighth consecutive quarter of year-over-year revenue growth, and a 15.5% sales increase for … Continue reading
Posted in Corporate Communications, In the News
Leave a comment
Recording Available for Transgenics Webinar
Late to the Webinar? Missed it? Want to hear it again? The Transgenic Technology Webinar, “Optimize Quality Assurance for Mouse Sperm Freezing and Rederivation using Computer Assisted Sperm Analysis (CASA), and Sneak Preview of Upcoming Webinar: Facilitate Fertilization through Laser-assisted IVF” … Continue reading
Congratulations to the New York Stem Cell Foundation for Being Named Time Magazine’s #1 Medical Breakthough of 2011
It is great to see that stem cell research has made tremendous strides in 2011. Hamilton Thorne applauds our customer, the New York Stem Cell Foundation (NYSCF), for being named Time Magazine’s #1 Medical Breakthrough for 2011. Here is an … Continue reading
David Wolf Featured in PharmaVoice’s 2012 Preview Issue
Hamilton Thorne CEO David Wolf provides insights on Research and Development trends in PharmaVoice’s November/December “2012 Preview” issue: http://viewer.zmags.com/publication/7e0af12c#/7e0af12c/42
